Examining the Clinical Characteristics, Treatment Patterns, Real-world Effectiveness, and Healthcare Resource Utilization of Patients With Dry Eye Disease

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

July 31, 2023

Primary Completion Date

December 30, 2024

Study Completion Date

December 30, 2024

Conditions
Dry Eye Disease
Interventions
DRUG

lifitegrast

patient newly started on medication will be followed for 6 months

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY